Main product
Current page: Home > News News
Rongda pharm strategically step into business of CRAMs
Release time: 2020.01.09
Moreover,with the clear trend of pharmaceutical manufacturing transfer from western countries to India and China, Rongda pharm strategically step into business of CRAMs,for which we have tens of experienced R&D scientists to support. With the principle of 'to be honest,quality first,credit as our life", we will always try our best to provide our customer first class product.Warmly welcome friends from both home and abroad to cooperate with us.
< Back >
Previous: CPHI China 2023
Next: Anastrozole,Lapatinib, Ib
Next: Anastrozole,Lapatinib, Ib